[KongchangAI]
Unverified78% confidenceTradeoffTime unknown

渗透速度与安全窗存在权衡:快速渗透(含渗透促进剂)起效快但吸收剂量高、全身副作用风险大;慢渗透缓释型更适合需长期使用的慢性痛,短期急性痛可选快渗型

1
Sources
78%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/297999
API
curl https://kongchang.com/api/v1/knowledge/claims/297999
MCP
get_claim(id=297999)